Suppr超能文献

公共卫生创新与获取的知识产权管理类型学:政策制定者的设计考量

A typology of intellectual property management for public health innovation and access: design considerations for policymakers.

作者信息

Taubman Antony

机构信息

Intellectual Property Division, World Trade Organization (WTO), Centre William Rappard, 154, Rue de Lausanne, 121121, Switzerland.

出版信息

Open AIDS J. 2010 Jan 19;4:4-24. doi: 10.2174/1874613601004020004.

Abstract

This paper seeks to set the practical discipline of public interest intellectual property (IP) management in public health into its broader policy context. The most immediate and direct impact of IP systems on public welfare results not from international standards nor from national legislation - though these norms are fundamentally important - but rather from the accumulated impact of numerous practical choices whether or not to seek IP protection; where and where not; and how any exclusive rights are deployed, by whom, and to what end. IP management is the essentially practical exercise of limited exclusive rights over protected subject matter, the judicious use of those rights to leverage outcomes that advance an institution's or a firm's objectives. Exclusive rights are used to construct and define knowledge-based relationships, to leverage access to technology and other necessary resources, and to enhance market-based incentives. IP management choices range across a broad spectrum, spanning public domain strategies, open or exclusive licensing, and strong exclusivity. The idea of 'exclusive rights', as a specific legal mechanism, can run counter to expectations of greater openness and accessibility, but actual outcomes will depend very much on how these mechanisms are used in practice. For public interest or public sector institutions concerned with health research and development, particularly the development of new medicines, IP management choices can be just as critical as they are for private firms, although a predominant institutional concentration on advancing direct public interest objectives may lead to significantly different approaches in weighing and exercising practical choices for IP management: even so, a private sector approach should not be conflated with exclusivity as an end in itself, nor need public interest IP management eschew all leverage over IP. This paper offers a tentative framework for a richer typology of those choices, to give a sense of practical options available and the factors that might guide their application, but without advocating any particular approach.

摘要

本文旨在将公共卫生领域公共利益知识产权(IP)管理这一实践学科置于更广泛的政策背景中。知识产权制度对公共福利的最直接和最直接影响并非源于国际标准或国家立法——尽管这些规范至关重要——而是源于众多实际选择的累积影响,即是否寻求知识产权保护;在何处寻求保护以及不在何处寻求保护;以及任何专有权如何被运用、由谁运用以及用于何种目的。知识产权管理本质上是对受保护主题事项行使有限专有权的实际操作,是明智地运用这些权利以实现推进机构或公司目标的成果。专有权被用于构建和界定基于知识的关系,以利用对技术和其他必要资源的获取,并增强基于市场的激励措施。知识产权管理选择范围广泛,涵盖公共领域战略、开放或独占许可以及强排他性。“专有权”这一特定法律机制的理念可能与对更大开放性和可及性的期望背道而驰,但实际结果将在很大程度上取决于这些机制在实践中的运用方式。对于关注健康研发,尤其是新药研发的公共利益或公共部门机构而言,知识产权管理选择与私营公司的选择同样关键,尽管机构主要专注于推进直接的公共利益目标可能导致在权衡和行使知识产权管理实际选择时采取显著不同的方法:即便如此,私营部门的方法不应被等同于将排他性本身作为目的,公共利益知识产权管理也无需摒弃对知识产权的所有利用。本文提供了一个初步框架,用于对这些选择进行更丰富的分类,以了解可用的实际选项以及可能指导其应用的因素,但并不倡导任何特定方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f75/2878976/537d6ddd064f/TOAIDJ-4-4_F1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验